Barclays PLC Acquires 17,097 Shares of Amdocs Limited (NASDAQ:DOX)

Barclays PLC grew its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 6.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 290,376 shares of the technology company's stock after purchasing an additional 17,097 shares during the quarter. Barclays PLC owned about 0.25% of Amdocs worth $25,402,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of DOX. Wealth Enhancement Advisory Services LLC lifted its holdings in Amdocs by 1.0% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 62,995 shares of the technology company's stock worth $4,972,000 after purchasing an additional 628 shares in the last quarter. Envestnet Portfolio Solutions Inc. boosted its position in shares of Amdocs by 2.1% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 24,260 shares of the technology company's stock valued at $1,915,000 after acquiring an additional 507 shares during the period. Blue Trust Inc. grew its stake in Amdocs by 18.0% during the second quarter. Blue Trust Inc. now owns 1,138 shares of the technology company's stock valued at $90,000 after acquiring an additional 174 shares in the last quarter. Boston Trust Walden Corp increased its holdings in Amdocs by 17.0% during the 2nd quarter. Boston Trust Walden Corp now owns 618,387 shares of the technology company's stock worth $48,803,000 after acquiring an additional 89,726 shares during the period. Finally, Raymond James & Associates lifted its stake in Amdocs by 15.8% in the 2nd quarter. Raymond James & Associates now owns 457,477 shares of the technology company's stock worth $36,104,000 after purchasing an additional 62,460 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Barclays reduced their price target on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research report on Thursday, November 14th. StockNews.com lowered Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Thursday, November 14th. Stifel Nicolaus assumed coverage on Amdocs in a research report on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price target for the company. Finally, Oppenheimer boosted their price objective on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $101.20.

Amdocs Price Performance

Shares of Amdocs stock traded down $1.14 during trading on Friday, hitting $87.30. 554,903 shares of the stock traded hands, compared to its average volume of 679,075. The stock has a market cap of $10.26 billion, a price-to-earnings ratio of 20.59, a PEG ratio of 1.45 and a beta of 0.72. The company has a quick ratio of 1.24, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $94.04. The firm's fifty day moving average is $88.05 and its 200-day moving average is $84.51.

Amdocs Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.479 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.19%. Amdocs's dividend payout ratio (DPR) is 45.28%.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.